Search research articles
Contact Us
Filters
Showing results (351-360 of 527) with videos related to
Page
of 53
Sort By:
Plos One
|
July 1, 2021
Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection
Hung-Yin Liu, Yi-Hung Lin, Pei-Ju Lin, et al.
Journal of the Chinese Medical Association : JCMA
|
June 2, 2021
The association between hepatitis C virus infection and renal function
Gantsetseg Gantumur, Batbold Batsaikhan, Ching-I Huang, et al.
Clinical and Molecular Hepatology
|
January 30, 2023
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, et al.
Biomedicines
|
November 11, 2022
Baseline Circulating miR-125b Levels Predict a High FIB-4 Index Score in Chronic Hepatitis B Patients after Nucleos(t)ide Analog Treatment
Jyun-Yi Wu, Yi-Shan Tsai, Chia-Chen Li, et al.
Scientific Reports
|
March 12, 2016
Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C
Ming-Ying Lu, Ching-I Huang, Chia-Yen Dai, et al.
Digestive Diseases and Sciences
|
November 14, 2019
Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C
Po-Yao Hsu, Cheng-Ting Hsu, Ming-Lun Yeh, et al.
Journal of Hepatology
|
February 17, 2020
Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection
Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
Scientific Reports
|
July 2, 2015
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial
Chen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Cancers
|
July 24, 2021
Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
Ming-Lun Yeh, Po-Cheng Liang, Pei-Chien Tsai, et al.
Scientific Reports
|
October 16, 2015
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
Chen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Page
of 53
Search research articles
Search
Showing results (351-360 of 527) with videos related to
Sort By:
Page
of 53
Plos One
|
July 1, 2021
Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection
Hung-Yin Liu, Yi-Hung Lin, Pei-Ju Lin, et al.
Journal of the Chinese Medical Association : JCMA
|
June 2, 2021
The association between hepatitis C virus infection and renal function
Gantsetseg Gantumur, Batbold Batsaikhan, Ching-I Huang, et al.
Clinical and Molecular Hepatology
|
January 30, 2023
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, et al.
Biomedicines
|
November 11, 2022
Baseline Circulating miR-125b Levels Predict a High FIB-4 Index Score in Chronic Hepatitis B Patients after Nucleos(t)ide Analog Treatment
Jyun-Yi Wu, Yi-Shan Tsai, Chia-Chen Li, et al.
Scientific Reports
|
March 12, 2016
Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C
Ming-Ying Lu, Ching-I Huang, Chia-Yen Dai, et al.
Digestive Diseases and Sciences
|
November 14, 2019
Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C
Po-Yao Hsu, Cheng-Ting Hsu, Ming-Lun Yeh, et al.
Journal of Hepatology
|
February 17, 2020
Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection
Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
Scientific Reports
|
July 2, 2015
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial
Chen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Cancers
|
July 24, 2021
Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
Ming-Lun Yeh, Po-Cheng Liang, Pei-Chien Tsai, et al.
Scientific Reports
|
October 16, 2015
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
Chen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Page
of 53